These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 24926579)

  • 1. The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophrenia.
    Brecher M; Rak IW; Melvin K; Jones AM
    Int J Psychiatry Clin Pract; 2000; 4(4):287-91. PubMed ID: 24926579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine demonstrates good tolerability and is associated with improvements in extrapyramidal symptoms in patients with schizophrenia switched from other antipsychotics: results of a naturalistic study.
    Hellewell JS
    Int J Psychiatry Clin Pract; 2007; 11(2):112-22. PubMed ID: 24937556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing an atypical antipsychotic.
    Sussman N
    Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S29-33. PubMed ID: 12570069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine ('Seroquel'); an effective and well-tolerated atypical antipsychotic.
    Meats P
    Int J Psychiatry Clin Pract; 1997; 1(4):231-9. PubMed ID: 24946189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of quetiapine in treatment-refractory schizophrenia: A case report.
    Reznik R Benatov P Sirota I
    Int J Psychiatry Clin Pract; 2000; 4(1):77-80. PubMed ID: 24927319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient satisfaction and acceptability of long-term treatment with quetiapine.
    Hellewell JS; Kalali AH; Langham SJ; McKellar J; Awad AG
    Int J Psychiatry Clin Pract; 1999; 3(2):105-13. PubMed ID: 24941092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials.
    Edwards SJ; Smith CJ
    Clin Ther; 2009 Jun; 31 Pt 1():1345-59. PubMed ID: 19698898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement without impairment: a review of clinical data for quetiapine in the treatment of schizophrenia.
    Tandon R
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S15-20. PubMed ID: 12832945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia.
    Chue P; Malla A; Bouchard RH; Lessard S; Ganesan S; Stip E; Johnson S; Chen E; Ahn YM; Kim YS; Robinson G; Schweikert C; Gendron A; Eriksson H;
    Curr Med Res Opin; 2013 Mar; 29(3):227-39. PubMed ID: 23281876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of second generation antipsychotics on leptin and ghrelin.
    Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine fumarate (Seroquel): a new atypical antipsychotic.
    Goldstein JM
    Drugs Today (Barc); 1999 Mar; 35(3):193-210. PubMed ID: 12973385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia.
    Gibert J; Giner J; Bobes J; Tafalla M; Herranz S; Ovejero C; Rico-Villademoros F; For The Sos Group 1 ; Gibert J; Giner J; Bobes J; Tafalla M; Herranz S; Ovejero C; Rico-Villademoros F; For The Sos Group 1
    Int J Psychiatry Clin Pract; 2007; 11(3):222-32. PubMed ID: 24941362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stable patient with schizophrenia--from antipsychotic effectiveness to adherence.
    Thomas P
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S115-22. PubMed ID: 17336766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nizatidine for the treatment of patients with quetiapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B; Kilic N
    Hum Psychopharmacol; 2004 Jan; 19(1):37-40. PubMed ID: 14716710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
    György B; Robert K; László C; Andrea J;
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine has a direct effect on the negative symptoms of schizophrenia.
    Tandon R
    Hum Psychopharmacol; 2004 Dec; 19(8):559-63. PubMed ID: 15486960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.